Literature DB >> 25470773

Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease.

Yang-Ming Yang1, Huijuan Yuan1, John G Edwards2, Yester Skayian2, Kanta Ochani3, Edmund J Miller3, Pravin B Sehgal1,4.   

Abstract

Chronic hypoxia typically elicits pulmonary hypertension (PH) in mice with a male-dominant phenotype. There is an opposite-sex bias in human PH, with a higher prevalence in women, but greater survival (the "estrogen paradox"). We investigated the involvement of the STAT5a/b species, previously established to mediate sexual dimorphism in other contexts, in the sex bias in PH. Mice with heterozygous or homozygous deletions of the STAT5a/b locus in vascular smooth muscle cells (SMCs) were generated in crosses between STAT5a/b(fl/fl) and transgelin (SM22α)-Cre(+/+) parents. Wild-type (wt) males subjected to chronic hypoxia showed significant PH and pulmonary arterial remodeling, with wt females showing minimal changes (a male-dominant phenotype). However, in conditional STAT5(+/-) or STAT5(-/-) mice, hypoxic females showed the severest manifestations of PH (a female-dominant phenotype). Immunofluorescence studies on human lung sections showed that obliterative pulmonary arterial lesions in patients with idiopathic pulmonary arterial hypertension (IPAH) or hereditary pulmonary arterial hypertension (HPAH), both male and female, overall had reduced STAT5a/b, reduced PY-STAT5 and reduced endoplasmic reticulum (ER) GTPase atlastin-3 (ATL3). Studies of SMCs and endothelial cell (EC) lines derived from vessels isolated from lungs of male and female IPAH patients and controls revealed instances of coordinate reductions in STAT5a, STAT5b and ATL3 in IPAH-derived cells, including SMCs and ECs from the same patient. Taken together, these data provide the first definitive evidence for a contribution of STAT5a/b to the sex bias in PH in the hypoxic mouse and implicate reduced STAT5 in the pathogenesis of the human disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25470773      PMCID: PMC4365065          DOI: 10.2119/molmed.2014.00180

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  70 in total

1.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  The influence of age and sex on the response of the right ventricle, pulmonary vasculature and carotid bodies to hypoxia in rats.

Authors:  P Smith; H Moosavi; M Winson; D Heath
Journal:  J Pathol       Date:  1974-01       Impact factor: 7.996

3.  Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver.

Authors:  Yijing Zhang; Ekaterina V Laz; David J Waxman
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

4.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

5.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

6.  Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.

Authors:  C A Gebert; S H Park; D J Waxman
Journal:  Mol Endocrinol       Date:  1997-04

7.  BCL6 represses Smad signaling in transforming growth factor-beta resistance.

Authors:  Degang Wang; Jianyin Long; Fangyan Dai; Min Liang; Xin-Hua Feng; Xia Lin
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

8.  Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression.

Authors:  Bing-Mei Zhu; Sara K McLaughlin; Risu Na; Jie Liu; Yongzhi Cui; Cyril Martin; Akiko Kimura; Gertraud W Robinson; Nancy C Andrews; Lothar Hennighausen
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

9.  Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension.

Authors:  Pravin B Sehgal; Jason E Lee
Journal:  Pulm Circ       Date:  2011 Jan-Mar       Impact factor: 3.017

10.  Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.

Authors:  Kevin White; Anne Katrine Johansen; Margaret Nilsen; Loredana Ciuclan; Emma Wallace; Leigh Paton; Annabel Campbell; Ian Morecroft; Lynn Loughlin; John D McClure; Matthew Thomas; Kirsty M Mair; Margaret R MacLean
Journal:  Circulation       Date:  2012-08-02       Impact factor: 29.690

View more
  8 in total

Review 1.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension.

Authors:  Yanan Sun; Shreya Sangam; Qiang Guo; Jian Wang; Haiyang Tang; Stephen M Black; Ankit A Desai
Journal:  Front Cardiovasc Med       Date:  2021-09-10

3.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

Review 4.  STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Huijuan Yuan; Edmund J Miller
Journal:  JAKSTAT       Date:  2015-09-18

5.  Up-Regulation of the Long Noncoding RNA X-Inactive-Specific Transcript and the Sex Bias in Pulmonary Arterial Hypertension.

Authors:  Shanshan Qin; Dan Predescu; Brandon Carman; Priyam Patel; Jiwang Chen; Miran Kim; Tim Lahm; Mark Geraci; Sanda A Predescu
Journal:  Am J Pathol       Date:  2021-04-06       Impact factor: 5.770

6.  Connexin 43 Plays a Role in Pulmonary Vascular Reactivity in Mice.

Authors:  Myo Htet; Jane E Nally; Andrew Shaw; Bradley E Foote; Patricia E Martin; Yvonne Dempsie
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

Review 7.  Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.

Authors:  Mohamed Ahmed; Edmund Miller
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30

8.  Smooth Muscle-Specific BCL6+/- Knockout Abrogates Sex Bias in Chronic Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.

Authors:  Yang-Ming Yang; Pravin B Sehgal
Journal:  Int J Endocrinol       Date:  2018-07-24       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.